These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1776591)

  • 41. Euhypnos Forte (temazepam) for resistant insomnia: a clinical trial.
    Moon CA; Schiller M
    J Int Med Res; 1979; 7(4):295-301. PubMed ID: 39857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nocturnal akathisia in Parkinson's disease: treatment with clozapine.
    Linazasoro G; Martí Massó JF; Suárez JA
    Mov Disord; 1993 Apr; 8(2):171-4. PubMed ID: 8474484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia.
    Erman MK; Loewy D; Scharf MB
    Curr Med Res Opin; 2004 Apr; 20(4):441-9. PubMed ID: 15119980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
    Admani AK; Verma S; Cordingley GJ; Harris RI
    Pharmatherapeutica; 1985; 4(2):132-40. PubMed ID: 4059292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance.
    Wesnes K; Warburton DM
    Neuropsychobiology; 1984; 11(4):255-9. PubMed ID: 6149491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-marketing surveillance of Euhypnos (temazepam): a new hypnotic.
    Fowler LK
    J Int Med Res; 1980; 8(4):295-9. PubMed ID: 6105982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative amnestic effects of benzodiazepine hypnotic agents.
    Scharf MB; Fletcher K; Graham JP
    J Clin Psychiatry; 1988 Apr; 49(4):134-7. PubMed ID: 2895761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P; Chiurulla C; Gambi D; Mennuni G; Pinto F
    Acta Neurol Belg; 1975; 75(1):5-10. PubMed ID: 1202895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altitude insomnia: studies during an expedition to the Himalayas.
    Nicholson AN; Smith PA; Stone BM; Bradwell AR; Coote JH
    Sleep; 1988 Aug; 11(4):354-61. PubMed ID: 2905069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the hypnotic effects of temazepam capsules and temazepam elixir.
    Patel AG; Gura R; Kurian T; Lambert MT; Steinert J; Priest RG
    Int Clin Psychopharmacol; 1991; 6(1):1-9. PubMed ID: 2071884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects.
    Glass JR; Sproule BA; Herrmann N; Streiner D; Busto UE
    J Clin Psychopharmacol; 2003 Jun; 23(3):260-8. PubMed ID: 12826988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
    Metman LV; Hoff J; Mouradian MM; Chase TN
    Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Fung VS; Herawati L; Wan Y; ;
    Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects.
    Lader M; Frcka G
    Pharmacopsychiatry; 1987 Mar; 20(2):67-71. PubMed ID: 2884682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H; Nakamura T; Kondo T; Narabayashi H
    Adv Neurol; 1993; 60():622-5. PubMed ID: 8420201
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline.
    Davis TL; Roznoski M; Burns RS
    Mov Disord; 1995 May; 10(3):349-51. PubMed ID: 7651456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Euhypnos forte, high dose temazepam for resistant insomnia: post-marketing surveillance in 10,057 patients unresponsive to conventional hypnotic dosage.
    Fowler LK; Schiller M
    J Int Med Res; 1980; 8(6):446-52. PubMed ID: 6108267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers.
    van Steveninck AL; Schoemaker HC; Pieters MS; Kroon R; Breimer DD; Cohen AF
    Clin Pharmacol Ther; 1991 Aug; 50(2):172-80. PubMed ID: 1868679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypnotic effect of chlormethiazole in geriatric patients during long-term treatment.
    Dehlin O
    Acta Psychiatr Scand Suppl; 1986; 329():112-5. PubMed ID: 3092586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.